Abstract
EPR spectra were recorded for methionine aminopeptidase from Escherichia coli (EcMetAP-I) samples (~2.5 mM) to which one and two equivalents of Mn(II) were added (the latter is referred to as [MnMn(EcMetAP-I)]). The spectra for each sample were indistinguishable except that the spectrum of [MnMn(EcMetAP-I)] was twice as intense. The EPR spectrum of [MnMn(EcMetAP-I)] exhibited the characteristic six-line g≈2 EPR signal of mononuclear Mn(II) with Aav(55Mn)=9.3 mT (93 G) and exhibited Curie-law temperature dependence. This signal is typical of Mn(II) in a ligand sphere comprising oxygen and/or nitrogen atoms. Other features in the spectrum were observed only as the temperature was raised from that of liquid helium. The temperature dependences of these features are consistent with their assignment to excited state transitions in the S=1, 2 ... 5 non-Kramer’s doublets, due to two antiferromagnetically coupled Mn(II) ions with an S=0 ground state. This assignment is supported by the observation of a characteristic 4.5 mT hyperfine pattern, and by the presence of signals in the parallel mode consistent with a non-Kramers’ spin ladder. Upon the addition of the anti-angiogenesis agent fumagillin to [MnMn(EcMetAP-I)], very small changes were observed in the EPR spectrum. MALDI-TOF mass spectrometry indicated that fumagillin was, however, covalently coordinated to EcMetAP-I. Therefore, the inhibitory action of this anti-angiogenesis agent on EcMetAP-I appears to involve covalent binding to a polypeptide component at or near the active site rather than direct binding to the metal ions.
Similar content being viewed by others
Abbreviations
- AMPP:
-
aminopeptidase P from E. coli
- EcMetAP-I:
-
methionine aminopeptidase from E. coli
- ZFS:
-
zero field splitting
References
Bradshaw RA (1989) Trends Biochem Sci 14:276–279
Meinnel T, Mechulam Y, Blanquet S (1993) Biochimie 75:1061–1075
Bradshaw RA, Brickey WW, Walker KW (1998) Trends Biochem Sci 23:263–267
Arfin SM, Bradshaw RA (1988) Biochemistry 27:7979–7984
Tobias JW, Shrader TE, Rocap G, Varshavsky A (1991) Science 254:1374–1377
Arfin SM, Kendall RL, Hall L, Weaver LH, Stewart AE, Matthews BW, Bradshaw RA (1995) Proc Natl Acad Sci USA 92:7714–7718
Bachmair A, Finley D, Varshavsky A (1986) Science 234:179–234
Rajagopalan PTR, Datta A, Pei D (1997) Biochemistry 36:13910–13918
Chang S-YP, McGary EC, Chang S (1989) J Bacteriol 171:4071–4072
Chang Y-H, Teichert U, Smith JA (1992) J Biol Chem 267:8007–8011
Li X, Chang Y-H (1995) Proc Natl Acad Sci USA 92:12357–12361
Miller CG, Kukral AM, Miller JL, Movva NR (1989) J Bacteriol 171:5215–5217
Kruger EA, Figg WD (2000) Expert Opin Invest Drugs 9:1383–1395
Tahirov TH, Oki H, Tsukihara T, Ogasahara K, Yutani K, Ogata K, Izu Y, Tsunasawa S, Kato I (1998) J Mol Biol 284:101–124
Lowther WT, Orville AM, Madden DT, Lim S, Rich DH, Matthews BW (1999) Biochemistry 38:7678–7688
Roderick LS, Matthews BW (1993) Biochemistry 32:3907–3912
Liu S, Widom J, Kemp CW, Crews CM, Clardy J (1998) Science 282:1324–1327
Oefner C, Douangamath A, D’Arcy A, Hafeli S, Mareque D, MacSweeney A, Padilla J, Pierau S, Schulz H, Thormann M, Wadman S, Dale GE ( 2003) J Mol Biol 332:13–21
Tahirov TH, Oki H, Tsukihara T, Ogasahara K, Izu Y, Tsunasawa S, Kato I, Yutani K (1997) Acta Crystallogr Sect D 53:798–801
D’souza VM, Bennett B, Copik AJ, Holz RC (2000) Biochemistry 39:3817–3826
Cosper NJ, D’souza V, Scott R, Holz RC (2001) Biochemistry 40:13302–13309
Meng L, Ruebush S, D’souza VM, Copik AJ, Tsunasawa S, Holz RC (2002) Biochemistry 41:7199–7208
Wang J, Sheppard GS, Lou P, Kawai M, Park C, Egan DA, Schneider A, Bouska J, Lesniewski R, Henkin J (2003) Biochemistry 42:5035–5042
D’souza VM, Swierczek SI, Cosper NJ, Meng L, Ruebush S, Copik AJ, Scott RA, Holz RC (2002) Biochemistry 41:13096–13105
D’souza VM, Holz RC (1999) Biochemistry 38:11079–11085
Griffith EC, Su Z, Turk BE, Chen S, Chang Y-H, Wu Z, Biemann K, Liu JO (1997) Chem Biol 4:461–471
Sin N, Meng L, Wang MQW, Wen JJ, Bornmann WG, Crews CM (1997) Proc Natl Acad Sci USA 94:6099–6103
Lowther WT, McMillen DA, Orville AM, Matthews BW (1998) Proc Natl Acad Sci USA 95:12153–12157
Zhou Y, Gou X-C, Yi T, Yoshimoto T, Pei D (2000) Anal Biochem 280:159–165
Brown RS, Lennon JJ (1995) Anal Chem 67:1998
Brown RS, Lennon JJ (1995) Anal Chem 67:3990
Bennett B, Holz RC (1997) J Am Chem Soc 119:1923–1933
Bennett B, Holz RC (1997) Biochemistry 36:9837–9846
Copik AJ, Nocek B, Swierczek SI, Ruebush S, SeBok J, D’souza VM, Peters J, Bennett B, Holz RC (2004) Biochemistry 43:(in press)
Reed GH, Markham GD (1984) Biol Magn Reson 6:73–142
Griscom DL, Griscom RE (1967) J Chem Phys 47:2711–2722
Schreurs JWH (1978) J Chem Phys 69:2151–2156
Rusnak F, Yu L, Todorovic S, Mertz P (1999) Biochemistry 38:6943–6952
Khangulov SV, Pessiki PJ, Barynin VV, Ash DE, Dismukes GC (1995) Biochemistry 34:2015–2025
Khangulov SV, Sossong TMJ, Ash DE, Dismukes GC (1998) Biochemistry 37:8539–8550
Baranowski J, Cukierda T, Jezowska-Trzebiatowska B, Kozlowski H (1979) J Magn Reson 33:585–593
Lowther TW, Zhang Y, Sampson PB, Honek JF, Matthews BW (1999) Biochemistry 38:14810–14819
Wilcox DE (1996) Chem Rev 96:2435–2458
Wilce MCJ, Bond CS, Dixon NE, Freeman HC, Guss JM, Lilley PE, Wilce JA (1998) Proc Natl Acd Sci USA 95:3472–3477
Zhang L, Crossley MJ, E. DN, Ellis PJ, Fisher ML, King GF, Lilley PE, MacLachlan D, Pace RJ, Freeman HC (1998) J Biol Inorg Chem 3:470–483
Drago RS (1992) Physical methods for chemists, 2nd edn. Saunders, Orlando, Fla., USA
Whiting AK, Boldt YR, Hendrich MP, Wackett LP, Que L (1996) Biochemistry 35:160–170
Yamamoto T, Sudo K, Fujita T (1994) Anticancer Res 14:XXX–XXX
Sin N, Meng L, Wang MQ, Wen JJ, Bornmann WG, Crews CM (1997) Proc Natl Acad Sci USA 94:6099–6103
Turk BE, Su Z, Liu JO (1998) Bioorg Med Chem 6:1163–1169
Acknowledgements
This work was supported by the National Institutes of Health (GM-56495 to R.C.H. and AI-056231 to B.B.) and the National Science Foundation (CHE-0240810 to R.C.H.). The Bruker ESP-300E EPR and ARX-400 NMR spectrometers were purchased with funds provided by the National Science Foundation (BIR-9413530 and CHE-9311730, respectively) and Utah State University. The methionyl aminopeptidase from E. coli was purified from a stock culture kindly provided by Drs Brian Matthews and W. Todd Lowther. The program EPRSim XOP was made available by Dr John Boswell, Oregon Graduate Institute.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
D’souza, V.M., Brown, R.S., Bennett, B. et al. Characterization of the active site and insight into the binding mode of the anti-angiogenesis agent fumagillin to the manganese(II)-loaded methionyl aminopeptidase from Escherichia coli. J Biol Inorg Chem 10, 41–50 (2005). https://doi.org/10.1007/s00775-004-0611-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00775-004-0611-7